MedullaX MedullaX
  • NHS & Policy
  • Government & Funding
  • Regulation & Safety
  • Clinical AI & Diagnostics
  • Workforce
  • UK HealthTech & Deals
  • Digital Health & Interoperability
  • Research & Evidence
Shop

MedullaX is an independent platform covering healthcare, medicine, AI, and digital health, providing clear news, analysis, and explainers for clinicians, professionals, and the public in the UK and worldwide.

  • Facebook
  • Twitter
  • Instagram
  • Pinteres

Facebook Twitter Instagram Pinterest
MedullaX MedullaX
  • NHS & Policy
  • Government & Funding
  • Regulation & Safety
  • Clinical AI & Diagnostics
  • Workforce
  • UK HealthTech & Deals
  • Digital Health & Interoperability
  • Research & Evidence
Shop
MedullaX MedullaX

What are You Looking for?

  • Clinical AI & Diagnostics
  • Digital Health & Interoperability
  • Government & Funding
  • NHS & Policy
  • Regulation & Safety
  • Research & Evidence
  • UK HealthTech & Deals
  • Workforce
Home patient safety

patient safety

31 posts
ByMedullax
February 16, 2026

Virtual Reality for Chronic Low Back Pain: A Randomised Trial Explores Efficacy

  • Clinical AI & Diagnostics
ByMedullax
February 16, 2026

AI Model Predicts CKD Progression in Type 2 Diabetes Across Diverse Groups

  • Clinical AI & Diagnostics
ByMedullax
February 7, 2026

AI Method Links CXR Evidence to CT Quantification for ILD Diagnosis

  • Clinical AI & Diagnostics
ByMedullax
February 7, 2026

MHRA Highlights Rare NAION Risk with Semaglutide (Wegovy, Ozempic, Rybelsus)

  • Government & Funding
  • Research & Evidence
ByMedullax
February 7, 2026

AI Model Predicts Intracranial Aneurysm Hemodynamics in Real Time

  • Clinical AI & Diagnostics
ByMedullax
February 5, 2026

AI in Prior Authorisation: Emerging Concerns for Patient Access

  • Clinical AI & Diagnostics
  • Regulation & Safety
ByMedullax
February 2, 2026

Applying Aviation Safety Principles to Clinical AI Collaboration

  • Clinical AI & Diagnostics
  • Regulation & Safety
ByMedullax
February 2, 2026

GLP-1 Medicines: New Government Guidance for Clinicians on Weight Loss and Diabetes

  • Government & Funding
ByMedullax
January 30, 2026

Mitigating Risks: Ensuring Patient Safety in Psychiatric Virtual Environments

  • Clinical AI & Diagnostics
  • Regulation & Safety
ByMedullax
January 30, 2026

Pancreatitis Risk: GLP-1 Agonist Warnings Strengthened Following Fatal Cases

  • Government & Funding
  • Research & Evidence
MedullaX MedullaX
MedullaX is an independent platform covering healthcare, medicine, AI, and digital health, providing clear news, analysis, and explainers for clinicians, professionals, and the public in the UK and worldwide.
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • AI Content Disclaimer
  • Editorial Policy
  • Corrections / Feedback Policy
  • Medical Disclaimer
Facebook Twitter Instagram Pinterest
©️ 2026 — MedullaX. All Rights Reserved.